__timestamp | ACADIA Pharmaceuticals Inc. | Takeda Pharmaceutical Company Limited |
---|---|---|
Wednesday, January 1, 2014 | 120000 | 1777824000000 |
Thursday, January 1, 2015 | 61000 | 1807378000000 |
Friday, January 1, 2016 | 17331000 | 1732051000000 |
Sunday, January 1, 2017 | 124901000 | 1770531000000 |
Monday, January 1, 2018 | 223807000 | 2097224000000 |
Tuesday, January 1, 2019 | 339076000 | 3291188000000 |
Wednesday, January 1, 2020 | 441755000 | 3197812000000 |
Friday, January 1, 2021 | 484145000 | 3569006000000 |
Saturday, January 1, 2022 | 517235000 | 4027478000000 |
Sunday, January 1, 2023 | 726437000 | 4263762000000 |
Monday, January 1, 2024 | 4263762000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, revenue generation is a key indicator of a company's market strength and innovation prowess. Over the past decade, Takeda Pharmaceutical Company Limited has consistently outperformed ACADIA Pharmaceuticals Inc. in terms of revenue. From 2014 to 2023, Takeda's revenue has surged, peaking at approximately 4.26 trillion in 2023, showcasing a robust growth trajectory. In contrast, ACADIA's revenue, while growing, reached a high of around 726 million in the same year. This stark difference highlights Takeda's dominant market position, generating over 5,800 times more revenue than ACADIA in 2023. The data also reveals a consistent upward trend for both companies, although ACADIA's growth is more modest. As we look to the future, the pharmaceutical landscape will continue to evolve, and these revenue trends will be crucial in shaping the industry's competitive dynamics.
Revenue Showdown: AstraZeneca PLC vs Takeda Pharmaceutical Company Limited
Who Generates More Revenue? Amgen Inc. or ACADIA Pharmaceuticals Inc.
Sanofi vs ACADIA Pharmaceuticals Inc.: Annual Revenue Growth Compared
Takeda Pharmaceutical Company Limited and Exelixis, Inc.: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Merus N.V.?
Takeda Pharmaceutical Company Limited and Novavax, Inc.: A Comprehensive Revenue Analysis
Walgreens Boots Alliance, Inc. and ACADIA Pharmaceuticals Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Lantheus Holdings, Inc. or ACADIA Pharmaceuticals Inc.?
Comparing Revenue Performance: ACADIA Pharmaceuticals Inc. or MorphoSys AG?
ACADIA Pharmaceuticals Inc. and Celldex Therapeutics, Inc.: A Comprehensive Revenue Analysis
ACADIA Pharmaceuticals Inc. and MiMedx Group, Inc.: A Comprehensive Revenue Analysis